Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Pediatric Blood & Cancer|March 28, 2009
Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinibKatherine A Janeway, Karen H Albritton, Annick D Van Den Abbeele, et al.
Investigational New Drugs|August 7, 2012
A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinomaAndrea Wang-Gillam, Stacey Plambeck-Suess, Peter Goedegebuure, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2008
Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206Brian I Rini, Susan Halabi, Jonathan E Rosenberg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2016
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network studyNabil Adra, Costantine Albany, Mary J Brames, et al.
JOP : Journal of the Pancreas|September 12, 2012
Multi-institutional experience with FOLFIRINOX in pancreatic adenocarcinomaParvin F Peddi, Sam Lubner, Robert McWilliams, et al.
American Journal of Clinical Oncology|July 26, 2021
Phase I Study of Docetaxel and Temsirolimus in Refractory Solid TumorsManik Amin, Feng Gao, Gretel Terrero, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Radiotherapy for epidermoid carcinoma of the anus: thirty years' experienceRobert J Myerson, Elesyia D Outlaw, Albert Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Activity of sunitinib in patients with advanced neuroendocrine tumorsMatthew H Kulke, Heinz-Josef Lenz, Neal J Meropol, et al.
Pageof 10